» Articles » PMID: 14668804

Ocular Immune Privilege: Therapeutic Opportunities from an Experiment of Nature

Overview
Journal Nat Rev Immunol
Date 2003 Dec 12
PMID 14668804
Citations 310
Authors
Affiliations
Soon will be listed here.
Citing Articles

Fibrotic Changes in Rhegmatogenous Retinal Detachment.

Harju N, Kauppinen A, Loukovaara S Int J Mol Sci. 2025; 26(3).

PMID: 39940795 PMC: 11817287. DOI: 10.3390/ijms26031025.


Clinical and Scientific Considerations for Whole Eye Transplantation: An Ophthalmologist's Perspective.

Gokoffski K, Washington K, Chuck R Transl Vis Sci Technol. 2025; 14(2):13.

PMID: 39918461 PMC: 11809445. DOI: 10.1167/tvst.14.2.13.


Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2).

Chi H, Ma L, Zeng F, Wang X, Peng P, Bai X Invest Ophthalmol Vis Sci. 2025; 66(2):15.

PMID: 39913165 PMC: 11806429. DOI: 10.1167/iovs.66.2.15.


Targeting ocular malignancies using a novel light-activated virus-like drug conjugate.

Ma S, Huis Int Veld R, Pinos E, Ossendorp F, Jager M Adv Ophthalmol Pract Res. 2025; 5(1):49-57.

PMID: 39911685 PMC: 11795595. DOI: 10.1016/j.aopr.2024.12.001.


Impact of COVID-19 on Ocular Surface Health: Infection Mechanisms, Immune Modulation, and Inflammatory Responses.

Huang D, Xuan W, Li Z Viruses. 2025; 17(1).

PMID: 39861857 PMC: 11768963. DOI: 10.3390/v17010068.